@vabio

Trade association focused on the advancement of #lifesciences, #biotech, #pharma, and #medicaldevice in Virginia.

 Virginia
vabio.org
Joined September 2008
  • Tweets9.8K
  • Following718
  • Followers3.6K
831Media
✨ Just over TWO WEEKS until WBB 2026! Connect. Dine. Inspire. Join Virginia’s life sciences community for an evening of insights, inspiration and meaningful connections. 📅 Oct. 29 | 4:30–8 PM 📍 Alexandria, VA Register: bit.ly/4cW9PKI #WBB2026
2
31
☕ Last call! Join Virginia Bio TOMORROW (Oct 13) for our coffee chat: ecosystem updates + Q&A with CEO John Newby, plus a look at VIPC's Tech Innovation Fund, non-dilutive funding for rural VA health tech. Register 👉 bit.ly/4dU1p6Y #VirginiaBio #RuralHealth
28
👏 Thank you to our WBB 2026 sponsors: @activationRVA, @VWR @VirginiaIPC, @Haleon_health, @WWFHVA, @AltriaNews, @DPRConstruction, @pfizer & @MedmarcIns! Interested in sponsoring? Contact Frank Wilton at Virginia Bio. Register: bit.ly/4cW9PKI #WBB2026
1
3
63
⏰ Last call! Tomorrow, Sept. 25, is the deadline to submit a Letter of Intent for Virginia Catalyst Grant Round 20, offering $200K–$800K in non-dilutive funding for collaborative life science projects. 📅 Due by 5 PM ET Learn more + apply: lnkd.in/efWWJMUb
1
32
🎉 Registration is open for WBB 2026! Connect, dine and be inspired alongside Virginia’s life sciences community. 📅 Oct. 29 | 4:30–8 PM 📍 Sheraton Suites Old Town Alexandria Save your seat at the table: bit.ly/4cW9PKI #WBB2026 #VirginiaBio
2
2
59
✨ Women Building Bio is back with a whole new experience! A new evening format. A new location. The same incredible life sciences community. 📅 Oct. 29 📍 Sheraton Suites Old Town Alexandria Keep your day plans. Save your evening. 🧬 🔗 bit.ly/468ojDv
1
42
#Biotech is entering one of its most promising eras, but the system built to deliver breakthrough treatments to patients hasn't kept pace with the science. Learn more in a new @RealClearHealth opinion from @IAmBiotech Board Chair Fritz Bittenbender: realclearhealth.com/articles…

America’s Next Biotech Challenge

Somewhere in America today, a patient is waiting for a treatment that does not yet exist. A family is waiting for a miracle. And thanks to extraordinary advances in biotechnology, a breakthrough may b

realclearhealth.com
49
The #340B program has turned into a profit-maximizer for large hospital systems as they pocket discounts that were meant to lower costs for vulnerable patients. See how the program has strayed from its intent in Virginia from @AIR340B: 340breform.org/340b-hospital…

Virginia - AIR340B

Are ‘s 340B Hospitals Putting Profits Over Patients? The 340B program should help vulnerable Virginia patients. Instead, 340B hospitals, contract […]

340breform.org
83
Last week, a federal court blocked CO's #PDAB attempt to set a UPL, confirming what VA and @GovernorVA already recognized – price caps threaten the innovation patients depend on. VA legislators must prioritize policies that protect access to treatments ➡️ ow.ly/YGzs50ZmTzV

Judge temporarily blocks Colorado’s first-in-the-nation price cap on a prescription drug

A federal judge has temporarily blocked a price cap set by Colorado's Prescription Drug Affordability Board on Amgen's blockbuster drug Enbrel.

coloradosun.com
2
48
JUST IN: Virginia is #3 in @CNBC's 2026 Top States for Business rankings, thanks in part to our $8B #biotech sector. As investment continues to pour in, it’s critical that our lawmakers support policies that protect local jobs & our business environment: ow.ly/gyqR50ZmpWy

America's Top States for Business 2026: See the full rankings and where your state finished

CNBC's annual study puts all 50 states to the test across 138 metrics and 10 categories of competitiveness. These are America's Top States for Business.

cnbc.com
1
4
189
New research ➡️ the U.S. policy environment could eliminate up to 55% of new drugs over the next 20 years. Lawmakers must act now to protect patients and Virginia's growing life science ecosystem. Learn more from @MagnoliaAccess: magnoliamarketaccess.com/ins…

U.S. Biopharmaceutical Innovation Ecosystem at Risk | Magnolia Market Access

Download Magnolia Market Access’ analysis of how research funding, regulatory capacity, and drug pricing pressures may affect future medicines, patient access, and U.S. biotech leadership.

magnoliamarketaccess.com
40
The lack of transparency in the federal #340B program raises concerns about whether discounts are reaching vulnerable Virginia patients. Thank you, @RepMGriffith, for shining light on abuse of the 340B program during a recent House E&C hearing. Learn more: ow.ly/seVT50ZcKgf

Unchecked growth of 340B program could undercut Va's boom in life sciences investment | Guest column

The 340B program has grown exponentially since its inception and is now the second largest federal prescription drug program, behind only Medicare Part D. Unlimited growth of this program would

richmond.com
1
32
🚀 Registration is open for the 12th Annual BHCR Week! Join biohealth leaders from across the region Sept. 15-17 for collaboration, innovation, investment, and growth. Plus, applications are now open for the Crab Trap Competition! 🔗 Register today: bit.ly/43Xal6a
29
🎉 Congratulations to our #THRiVE2026 survey winners, who have received complimentary registration to a future VA Bio event! Thank you to everyone who attended and shared feedback. 📸 Relive THRiVE through the photo gallery: bit.ly/4399mzB
30
NEW! In @CardinalNewsVA, learn more from @HarryGewanter about how #340B has run off course and drives up costs for families in VA. @RepMGriffith is right to demand answers and hold hospitals accountable for how billions in 340B savings are being used. ➡️ bit.ly/4tYQWML

Richmond physician: Griffith is right to demand greater transparency in little-known federal program

What was meant to be a patient-focused program is now a hospital markup program where large, tax-exempt hospital systems buy discounted drugs, mark them up by as much as 1,000% or more and bill pat…

cardinalnews.org
4
1
142
🎉Welcome new Virginia Bio members: PILMA, Glen Research, Nexus CMC Advisors, and S1P Therapeutics Inc. Excited to have them join our life sciences community and advance innovation together. #WelcomeNewMembers #LifeSciences #Innovation #Community
26
🎉 Congratulations to Scott Meza and Nikki Hastings, recipients of VA Bio’s 2026 Outstanding Contributions to Bioscience Award! It was an honor to recognize their leadership and impact on Virginia’s life sciences ecosystem at #THRiVE2026 🧬 Read more: bit.ly/4wHpoxX
33
Thank you @GovernorVA for vetoing SB271/HB483 and protecting patient access to medicines while supporting VA's life sciences economy! Virginia must continue fostering innovation, investment and patient-centered healthcare solutions that increase access and reduce patient costs.
25
NEW! In @VirginianPilot, VA Bio CEO John Newby thanks @MarkWarner for co-sponsoring the PBM Price Transparency and Accountability Act — a meaningful step toward lower health care costs and greater accountability for Virginia patients. Read more: bit.ly/4d1ce67

Column: Warner helps move health care reform in the right direction

PBM reform championed by Sen. Warner is a necessary step to lower health care costs for patients, VA Bio’s John Newby writes in a guest column

pilotonline.com
47
Virginia Bio applauds @GovernorVA for rejecting a rushed government price-setting scheme in SB271/HB483. By requiring the federal MFP provisions to be re-enacted in 2027, her amendment blocks harmful price caps from taking effect in Virginia.
1
74
Load more